
The Australian-trained physician built a career at the border of medicine and money, where a molecule needs both evidence and a route forward.
Justin Bekelman is the co-founder and CEO of Daymark Health, a Philadelphia-based value-based oncology company building a tech-enabled medical group that wraps clinical, mental health, and social support around people facing cancer. A radiation oncologist with roughly 200 published research articles, he spent two decades at the University of Pennsylvania, where he founded the Penn Center for Cancer Care Innovation at the Abramson Cancer Center before leaving to build a company that contracts directly with health plans to take on total cost of care. Daymark launched publicly in 2025 with $11.5M in seed funding and closed a $20M Series A in September 2025.
Joseph Antos is one of Washington's most-quoted health economists, the Wilson H. Taylor Scholar in Health Care and Retirement Policy and a senior fellow emeritus at the American Enterprise Institute. A University of Rochester PhD who started as a Cornell math major, he spent decades inside the federal machinery - the Congressional Budget Office, the Council of Economic Advisers, OMB, the Department of Labor and HHS - before becoming AEI's go-to voice on Medicare, the federal budget, and market-based reform. He has advised the World Bank and foreign governments, served terms regulating hospital rates in Maryland, and teaches at George Washington University.

Emily Oster is a Harvard-trained economist, Brown University professor, and the mind behind ParentData - a platform transforming how millions of parents make decisions. With four consecutive New York Times bestsellers, TIME's 100 Most Influential People recognition, and over a million books sold, she wields data like a scalpel against pregnancy myths and parenting guilt, convincing readers that evidence beats anxiety every time.